The International Market Analysis Research and Consulting Group (IMARC Group) has been keeping the top position in terms of provision consultancy services on management strategy and market for above 5 years.
IMARC Group serves customers from diverse industry areas in various regions of the globe by identifying their premium-value biz opps, dealing with their most burning issues, and converting their businesses. The company bears its clients a hand in improving decision-making and strategy-planning processes as well as in moving their business to a higher level.
The reports published by IMARC offer precise information on a slew of industries such as pharmaceutical, high-technology, advanced materials, food and beverage, biotechnology, nanotechnology, tourism and travel and a far more. The reports include detailed market analyses, overviews and forecasts, reviews of the economic and technological developments, profiles of the dominant companies, market/product assessments, etc. IMARC’s research approach unites deep insight into the market dynamics together with strong cooperation with each level of the client organization.
Publications found:
9,055
Sort by:
Surgical Site Infections Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major surgical site infections markets reached a value of US$ 664.9 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,174.5 Million by 2034, exhibiting a growth rate (...
May 2024
135 pages
Synucleinopathies Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major synucleinopathies markets reached a value of US$ 661.9 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,095.2 Million by 2034, exhibiting a growth rate (CAGR) o...
May 2024
131 pages
Systemic Juvenile Idiopathic Arthritis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major systemic juvenile idiopathic arthritis markets reached a value of US$ 900 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,250 Million by 2034, exhibiting a gro...
May 2024
135 pages
Tauopathies Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major tauopathies markets reached a value of US$ 661.6 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,493.0 Million by 2034, exhibiting a growth rate (CAGR) of 7.68...
May 2024
138 pages
Thyroid Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major thyroid cancer markets reached a value of US$ 303.0 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,624.3 Million by 2034, exhibiting a growth rate (CAGR) of 1...
May 2024
139 pages
Thyroid Eye Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major thyroid eye disease markets reached a value of US$ 2,122.9 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 4,139.7 Million by 2034, exhibiting a growth rate (CAG...
May 2024
131 pages
Tourette Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major Tourette syndrome markets reached a value of US$ 1,818.1 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2,710.2 Million by 2034, exhibiting a growth rate (CAGR)...
May 2024
135 pages
Treatment Resistant Depression Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major treatment resistant depression markets reached a value of US$ 3,295.3 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 6,286.7 Million by 2034, exhibiting a growt...
May 2024
139 pages
Triple-negative Breast Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The triple-negative breast cancer market reached a value of US$ 490.5 Million across the top 7 markets (US, EU4, UK, and Japan) in 2023. Looking forward, IMARC Group expects the top 7 markets to reach...
May 2024
129 pages
Type 1 Diabetes Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The type 1 diabetes market reached a value of US$ 5.6 Billion across the top 7 markets (US, EU4, UK, and Japan) in 2023. Looking forward, IMARC Group expects the top 7 markets to reach US$ 9.4 Billion...
May 2024
129 pages
Type 2 Diabetes Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The type 2 diabetes market reached a value of US$ 23.4 Billion across the top 7 markets (US, EU4, UK, and Japan) in 2023. Looking forward, IMARC Group expects the top 7 markets to reach US$ 42.8 Billi...
May 2024
140 pages
Uveal Melanoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major uveal melanoma markets reached a value of US$ 980 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,550 Million by 2034, exhibiting a growth rate (CAGR) of 4.22%...
May 2024
131 pages
